Fetal tracheal occlusion for severe congenital diaphragmatic hernia
Official title: Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
Run by Children's Hospital Medical Center, Cincinnati · NCT02986087 · Data updated 2026-11-12
This study is testing if a procedure called fetal tracheal occlusion can help improve lung development in unborn babies with severe congenital diaphragmatic hernia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Children's Hospital Medical Center, Cincinnati Academic / other |
| Locations | 1 site (Cincinnati, Ohio) |
| Status | Recruiting |
| Started | November 2016 |
| Main results expected | December 2025 |
| Study ends | December 2026 |
| Registry record updated | May 11, 2025 |
| Trial ID | NCT02986087 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant individuals with a singleton fetus diagnosed with severe congenital diaphragmatic hernia and specific ultrasound criteria.
✕Probably not a fit
Patients with multi-fetal pregnancies or those under 18 years old will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the feasibility and efficacy of fetal tracheal occlusion (FETO) in fetuses diagnosed with severe congenital diaphragmatic hernia (CDH) characterized by liver-up and significant pulmonary hypoplasia. Eligible participants include singleton pregnancies with specific ultrasound findings and gestational age criteria. The intervention aims to improve lung development and overall outcomes for affected fetuses. The study is conducted at Cincinnati Children's Hospital Medical Center, focusing on a targeted patient population.
Why it matters
Potential benefit: If successful, this intervention could significantly improve lung development and survival rates for fetuses with severe congenital diaphragmatic hernia.
How similar studies have gone: Other studies have shown promise with fetal interventions for congenital diaphragmatic hernia, indicating potential for success with this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Isolated CDH with liver up * Severe pulmonary hypoplasia with ultrasound O/E LHR \<25% at the time of surgery * Gestational age at FETO procedure 27 weeks 0 days to 29 weeks 6 days * Moderate pulmonary hypoplasia with ultrasound O/E LHR \<30% and liver-up at the time of surgery * Gestational age at FETO procedure 30 weeks 0 days to 31 weeks 6 days in this moderate category * Maternal age greater than or equal to 18 years * Gestational age at enrollment prior to 29 weeks 6 days, or 31 weeks 6 days in moderate category * Normal karyotype or FISH * Normal fetal echocardiogram * Singleton pregnancy * Willing to remain in the greater Cincinnati area for remainder of pregnancy * Family considered and decline option of termination of the pregnancy at less than 24 weeks 0 days * Family meets psychosocial criteria Exclusion Criteria: * Patient \< 18 years old * Multi-fetal pregnancy * Rubber latex allergy * Preterm labor, cervix shortened (\<15 mm) or uterine anomaly strongly predisposing to preterm labor, placenta previa * Bilateral CDH, isolated left sided CDH with an O/E \> 30% * Additional fetal anomaly by ultrasound, MRI, or echocardiogram * Chromosomal abnormalities * Maternal contraindications to fetoscopic surgery or severe maternal condition in pregnancy * Incompetent cervix with or without a cerclage * Placental abnormalities known at time of enrollment * Maternal HIV, Hepatits B, Hepatitis C * Maternal uterine anomaly * No safe or technically feasible fetoscopic approach to balloon placement * Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy
Where it's running
-
Cincinnati Children's Hospital Medical Center (CCHMC)
Cincinnati, Ohio, United States Recruiting
Study contacts
- Study coordinator: Foong-Yen Lim, MD
- Email: Foong-Yen.Lim@cchmc.org
- Phone: (513) 636-6259
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fetal tracheal occlusion (FETO) for severe congenital diaphragmatic hernia
This trial will test whether fetal endoluminal tracheal occlusion (FETO) helps fetuses with severe congenital diaphragmatic hernia and intrathoracic liver herniation survive to hospital discharge.
-
Fetal treatment for congenital diaphragmatic hernia
This study is testing a new way to treat congenital diaphragmatic hernia in unborn babies by placing a balloon in their airway to help their lungs grow before they are born.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Fetoscopic tracheal balloon occlusion for severe left congenital diaphragmatic hernia
This research will try placing a temporary balloon in the fetal windpipe to help lungs grow in pregnancies where the baby has a severe left congenital diaphragmatic hernia.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.